Newron Pharmaceuticals - Crucial upcoming datasets for evenamide
Newron has released its H123 results and presented an overview of its upcoming clinical activities assessing evenamide as a potential treatment for...
185 Views
Newron Pharmaceuticals - Encouraging efficacy data from evenamide trial
Newron has presented new efficacy data from its Phase II evenamide trial (study 014/015) at the CINP World Congress of Neuropsychopharmacology and...
226 Views
Newron Pharmaceuticals - Positive top-line data to support clinical progress
Newron Pharmaceuticals has announced positive top-line results from its Phase II trial (study 014) assessing evenamide, a glutamate modulator, as...
267 Views
Newron Pharmaceuticals - A year ahead of clinical milestones for evenamide
Newron has released its annual report and provided an operational overview for evenamide as a potential schizophrenia therapy. Positive interim...
307 Views
Newron Pharmaceuticals - Evenamide efficacy still going strong after 52 weeks
Newron Pharmaceuticals has announced positive interim results from the first 100 randomised patients completing one year of treatment (77 out of...
325 Views